INIBIO Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines. (NCT07622004) | INIBIO Co., Ltd. | 2021-05-27 |
Track INIBIO Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.